bioAffinity Technologies Aktie
WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m
WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m